APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sitagliptin Metformin Extended Release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sitagliptin Metformin Extended Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025182 pages

Choose your research edition.

Industry ResearchSitagliptin Metformin Extended Release Tablets Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Sitagliptin Metformin Extended Release Tablets Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Sitagliptin Metformin Extended Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sitagliptin Metformin Extended Release Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sitagliptin Metformin Extended Release Tablets Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Sitagliptin Metformin Extended Release Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sitagliptin Metformin Extended Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sitagliptin Metformin Extended Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sitagliptin Metformin Extended Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sitagliptin Metformin Extended Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sitagliptin Metformin Extended Release Tablets include Chia Tai Tianqing Pharmaceutical Group, Jiangsu Xuantai Pharmaceutical Co., Ltd., Jiangsu Anbisheng Pharmaceutical Co., Ltd., Sandoz Pty Ltd, Merck & Co., Inc. and Abbott, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sitagliptin Metformin Extended Release Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sitagliptin Metformin Extended Release Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sitagliptin Metformin Extended Release Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sitagliptin Metformin Extended Release Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Sitagliptin Metformin Extended Release Tablets Segment by Company

Chia Tai Tianqing Pharmaceutical Group

Jiangsu Xuantai Pharmaceutical Co., Ltd.

Jiangsu Anbisheng Pharmaceutical Co., Ltd.

Sandoz Pty Ltd

Merck & Co., Inc.

Abbott

Sitagliptin Metformin Extended Release Tablets Segment by Type

Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg

Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg

Sitagliptin Metformin Extended Release Tablets Segment by Application

Hospital

Clinic

Other

Sitagliptin Metformin Extended Release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sitagliptin Metformin Extended Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sitagliptin Metformin Extended Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sitagliptin Metformin Extended Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sitagliptin Metformin Extended Release Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sitagliptin Metformin Extended Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sitagliptin Metformin Extended Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sitagliptin Metformin Extended Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sitagliptin Metformin Extended Release Tablets Industry Trends Table 2. Sitagliptin Metformin Extended Release Tablets Industry Drivers Table 3. Sitagliptin Metformin Extended Release Tablets Industry Opportunities and Challenges Table 4. Sitagliptin Metformin Extended Release Tablets Industry Restraints Table 5. Global Sitagliptin Metformin Extended Release Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sitagliptin Metformin Extended Release Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Manufacturers Table 9. Global Sitagliptin Metformin Extended Release Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Sitagliptin Metformin Extended Release Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sitagliptin Metformin Extended Release Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sitagliptin Metformin Extended Release Tablets Manufacturers, Product Type & Application Table 13. Global Sitagliptin Metformin Extended Release Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sitagliptin Metformin Extended Release Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg Table 17. Major Manufacturers of Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg Table 18. Global Sitagliptin Metformin Extended Release Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2021-2026) Table 22. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2027-2032) Table 23. Global Sitagliptin Metformin Extended Release Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Sitagliptin Metformin Extended Release Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2021-2026) Table 35. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2027-2032) Table 36. Global Sitagliptin Metformin Extended Release Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Sitagliptin Metformin Extended Release Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Region (2021-2026) Table 44. Global Sitagliptin Metformin Extended Release Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Sitagliptin Metformin Extended Release Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Sitagliptin Metformin Extended Release Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Sitagliptin Metformin Extended Release Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Sitagliptin Metformin Extended Release Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2027-2032) Table 63. Chia Tai Tianqing Pharmaceutical Group Company Information Table 64. Chia Tai Tianqing Pharmaceutical Group Business Overview Table 65. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product Portfolio Table 67. Chia Tai Tianqing Pharmaceutical Group Recent Development Table 68. Jiangsu Xuantai Pharmaceutical Co., Ltd. Company Information Table 69. Jiangsu Xuantai Pharmaceutical Co., Ltd. Business Overview Table 70. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio Table 72. Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Development Table 73. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Company Information Table 74. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Business Overview Table 75. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio Table 77. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Development Table 78. Sandoz Pty Ltd Company Information Table 79. Sandoz Pty Ltd Business Overview Table 80. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product Portfolio Table 82. Sandoz Pty Ltd Recent Development Table 83. Merck & Co., Inc. Company Information Table 84. Merck & Co., Inc. Business Overview Table 85. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product Portfolio Table 87. Merck & Co., Inc. Recent Development Table 88. Abbott Company Information Table 89. Abbott Business Overview Table 90. Abbott Sitagliptin Metformin Extended Release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Abbott Sitagliptin Metformin Extended Release Tablets Product Portfolio Table 92. Abbott Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Sitagliptin Metformin Extended Release Tablets Distributors List Table 96. Sitagliptin Metformin Extended Release Tablets Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Sitagliptin Metformin Extended Release Tablets Product Image Figure 2. Global Sitagliptin Metformin Extended Release Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sitagliptin Metformin Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Sitagliptin Metformin Extended Release Tablets Sales (2021-2032) & (K Units) Figure 5. Global Sitagliptin Metformin Extended Release Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sitagliptin Metformin Extended Release Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg Image Figure 9. Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg Image Figure 10. Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021-2032) Figure 39. China Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Sitagliptin Metformin Extended Release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Sitagliptin Metformin Extended Release Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Sitagliptin Metformin Extended Release Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Sitagliptin Metformin Extended Release Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Sitagliptin Metformin Extended Release Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Sitagliptin Metformin Extended Release Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
  • Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chia Tai Tianqing Pharmaceutical Group
  • Jiangsu Xuantai Pharmaceutical Co., Ltd.
  • Jiangsu Anbisheng Pharmaceutical Co., Ltd.
  • Sandoz Pty Ltd
  • Merck & Co., Inc.
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sitagliptin Metformin Extended Release Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sitagliptin Metformin Extended Release Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sitagliptin Metformin Extended Release Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sitagliptin Metformin Extended Release Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sitagliptin Metformin Extended Release Tablets Market Dynamics
  1. 2.1 Sitagliptin Metformin Extended Release Tablets Industry Trends
  2. 2.2 Sitagliptin Metformin Extended Release Tablets Industry Drivers
  3. 2.3 Sitagliptin Metformin Extended Release Tablets Industry Opportunities and Challenges
  4. 2.4 Sitagliptin Metformin Extended Release Tablets Industry Restraints
3 Sitagliptin Metformin Extended Release Tablets Market by Manufacturers
  1. 3.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sitagliptin Metformin Extended Release Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sitagliptin Metformin Extended Release Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sitagliptin Metformin Extended Release Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sitagliptin Metformin Extended Release Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Sitagliptin Metformin Extended Release Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sitagliptin Metformin Extended Release Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sitagliptin Metformin Extended Release Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sitagliptin Metformin Extended Release Tablets Tier 1, Tier 2, and Tier 3
4 Sitagliptin Metformin Extended Release Tablets Market by Type
  1. 4.1 Sitagliptin Metformin Extended Release Tablets Type Introduction
  2. 4.1.1 Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
  3. 4.1.2 Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
  4. 4.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Type
  5. 4.2.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type
  9. 4.3.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type (2021-2032)
5 Sitagliptin Metformin Extended Release Tablets Market by Application
  1. 5.1 Sitagliptin Metformin Extended Release Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Application
  6. 5.2.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Sitagliptin Metformin Extended Release Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application
  10. 5.3.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2021-2032)
6 Global Sitagliptin Metformin Extended Release Tablets Sales by Region
  1. 6.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sitagliptin Metformin Extended Release Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Sitagliptin Metformin Extended Release Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Sitagliptin Metformin Extended Release Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sitagliptin Metformin Extended Release Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sitagliptin Metformin Extended Release Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sitagliptin Metformin Extended Release Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region
  1. 7.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region
  2. 7.1.1 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Sitagliptin Metformin Extended Release Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sitagliptin Metformin Extended Release Tablets Revenue (2021-2032)
  8. 7.2.2 North America Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sitagliptin Metformin Extended Release Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sitagliptin Metformin Extended Release Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sitagliptin Metformin Extended Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chia Tai Tianqing Pharmaceutical Group
  2. 8.1.1 Chia Tai Tianqing Pharmaceutical Group Company Information
  3. 8.1.2 Chia Tai Tianqing Pharmaceutical Group Business Overview
  4. 8.1.3 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product Portfolio
  6. 8.1.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments
  7. 8.2 Jiangsu Xuantai Pharmaceutical Co., Ltd.
  8. 8.2.1 Jiangsu Xuantai Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Jiangsu Xuantai Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio
  12. 8.2.5 Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Jiangsu Anbisheng Pharmaceutical Co., Ltd.
  14. 8.3.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product Portfolio
  18. 8.3.5 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Sandoz Pty Ltd
  20. 8.4.1 Sandoz Pty Ltd Company Information
  21. 8.4.2 Sandoz Pty Ltd Business Overview
  22. 8.4.3 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product Portfolio
  24. 8.4.5 Sandoz Pty Ltd Recent Developments
  25. 8.5 Merck & Co., Inc.
  26. 8.5.1 Merck & Co., Inc. Company Information
  27. 8.5.2 Merck & Co., Inc. Business Overview
  28. 8.5.3 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product Portfolio
  30. 8.5.5 Merck & Co., Inc. Recent Developments
  31. 8.6 Abbott
  32. 8.6.1 Abbott Company Information
  33. 8.6.2 Abbott Business Overview
  34. 8.6.3 Abbott Sitagliptin Metformin Extended Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Abbott Sitagliptin Metformin Extended Release Tablets Product Portfolio
  36. 8.6.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sitagliptin Metformin Extended Release Tablets Value Chain Analysis
  2. 9.1.1 Sitagliptin Metformin Extended Release Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sitagliptin Metformin Extended Release Tablets Production Mode & Process
  6. 9.2 Sitagliptin Metformin Extended Release Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sitagliptin Metformin Extended Release Tablets Distributors
  9. 9.2.3 Sitagliptin Metformin Extended Release Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst